Long COVID Signal

@longcovidsignal.bsky.social

Tracking the latest Long COVID research so you don't have to.

No marked organ deficits found across brain, heart, lung, kidney, or exercise capacity vs three control groups in UK case-control study. Only vascular differences emerged: ~2x higher odds of elevated blood pressure, rising to ~3x in those with fatigue. (n=349) #LongCovid

Multi-organ structural and functional deficits in association with long COVID: a population-based case-control study - PubMed

Jointly funded by the National Institute for Health and Care Research and UK Research and Innovation (CONVALESCENCE, COV-LT-0009, MC_PC_20051).

pubmed.ncbi.nlm.nih.gov

Wearable heart rate variability was lower in patients vs healthy controls during daily activities, exercise, and sleep. Autonomic recovery after exercise remained impaired for 24 hours, linking post-exertional malaise risk to overexertion in observational study. #LongCovid

Wearable Heart Rate Variability Monitoring, Autonomic Dysfunction and Post-exertional Malaise in Long COVID: An Observational Study - PubMed

These results confirm the applicability of wearables to assess autonomic function and manage overexertion in patients with long COVID.

pubmed.ncbi.nlm.nih.gov

ADDRESS-LC is a phase 2 triple-blind trial testing bezisterim, an oral anti-inflammatory that crosses the blood-brain barrier, for brain fog and fatigue. 20 mg twice daily vs placebo for 12 weeks across US sites. (n=208) #LongCovid

ADDRESS-LC: study protocol for a phase 2, triple-blind, randomised, placebo-controlled trial to evaluate the efficacy and safety of bezisterim (NE3107) in adults with long COVID - PubMed

NCT06847191.

pubmed.ncbi.nlm.nih.gov